专长肝肿瘤的诊治及肝移植。 长期从事肝癌及肝移植的临床和基础研究工作，已积累1000余例肝切除和300余例肝移植临床经验，能够成功施行过去视为禁区的合并门静脉主干癌栓肝癌、尾状叶肝癌、巨大肝癌和侵犯下腔静脉的肝癌等手术以及肝脏移植手术。,学术任职国际外科医师和胃肠病学家委员会(IASGO)会员。“Expert Opinion On Drug Metabolism and Toxicology” “中华实验外科杂志”等杂志审稿专家。,研究方向肝癌的早起发生以及肝癌切除术后或肝移植术后转移复发的分子机制及防治,教学工作为本科生上大课4学时;协助指导硕士研究生3名、博士研究生2名。,所获奖项获国家科技进步二等奖及上海市科技进步一等奖(第五完成人)各一项。,基本课题获国家自然科学基金 2项，上海市自然科学基金 1项。,论文1) Wang Z, Zhou J, Fan J, Qiu SJ, Yu Y, Huang XW, Tang ZY. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma. Clin Cancer Res. 2008; 14(16):5124-30. IF=7.837 2) Wang Z, Hu J, Qiu SJ, Huang XW, Dai Z, Tan CJ, Zhou J, Fan J. An investigation of the effect of sorafenib on tumour growth and recurrence after liver cancer resection in nude mice independent of phosphorylated extracellular signal-regulated kinase levels. Expert Opin Investig Drugs. 2011; 20(8):1039-45. IF=4.744 3) Wang Z, Zhou J, Fan J, Qiu SJ, Yu Y, Huang XW, Sun J, Tan CJ, Dai Z. Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth. Expert Opin Investig Drugs. 2009; 18(11):1595-604. IF=4.744 4) Wang Z, Zhou J, Fan J, Tan CJ, Qiu SJ, Yu Y, Huang XW, Tang ZY. Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma. J Cancer Res Clin Oncol. 2009; 135(5):715-22. IF=2.914 5) Hu J, Wang Z(共同第一), Liao BY, Yu L, Gao X, Lu S, Wang S, Dai Z, Zhang X, Chen Q, Qiu SJ, Wu Y, Zhu H, Fan J, Zhou J, Wang J.Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients. Int J Cancer. 2014 Feb 1. doi: 10.1002/ijc.28757. [Epub ahead of print] IF=6.198 6) Hu J, Wang Z(共同第一), Tang CJ, Liao BY, Xu M, Dai Z, Qiu SJ, Huang XW, Sun J, Sun QM, He YF, Song K, Pan Q, Wu Y, Fan J, Zhou J. Plasma microRNA, a potential biomarker for acute rejection after liver transplantation. Transplantation. 2013; 27; 95(8):991-9. IF=3.781 7) Hu J, Wang Z (共同第一), Fan J, Dai Z, He YF, Qiu SJ, Huang XW, Sun J, Xiao YS, Song K, Shi YH, Sun QM, Yang XR, Shi GM, Yu L, Yang GH, Ding ZB, Gao Q, Tang ZY, Zhou J. Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation. PLoS One. 2011; 6(10):e26003. IF=3.73
